Connecticut Innovations Reports Record $66.5 Million in Proceeds for FY2026
Connecticut Innovations (CI) generated a record $66.5 million in proceeds during fiscal year 2026, driven by major exits including the acquisition of Halda Therapeutics and Veradermics' IPO. The state-backed venture capital firm also invested $59.3 million across early-stage companies and funds.
